Máj- és epeúti rák: vizsgálatok itt: Ausztria
15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
- Where
- Krems, Linz, Vienna, Wels
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07284121 - No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Linz, Sankt Pölten, Vienna
- Életkor
- 18 év to 130 év
- People
- 4000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - 3. fázisTaking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Graz, Linz, Salzburg, Vienna, Wiener Neustadt
- Életkor
- 18 év to 99 év
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - No phaseTaking peopleSARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors
- Where
- Graz, Linz, Sankt Pölten, Sankt Veit an der Glan, Wels
- People
- 200
- Run by
- Medical University of Graz
See details and how to joinNCT07341321 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Graz, Vienna
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 3. fázisTaking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Linz, Wiener Neustadt
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 · EU 2023-505660-11-00 - No phaseTaking peopleDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT07717437 - No phaseNot yet taking people in AusztriaDigitally Supported Prehabilitation Before Major Visceral Cancer Surgery
- Where
- Saint Veit Im Pongau, Salzburg
- Életkor
- 18 év and over
- People
- 30
- Run by
- Ludwig Boltzmann Institute for Digital Health and Prevention
See details and how to joinNCT07658313 - 2. fázisTaking people– IKF/AIO-QUINTIS – A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer without Active Liver Metastases
- Where
- Linz, Salzburg, Wiener Neustadt
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
See details and how to join2024-519929-38-00 · EU 2024-519929-38-00 - No phaseNot yet taking people in Ausztria3D Liver Volumetry
- Where
- Graz
- Életkor
- 18 év and over
- People
- 25
- Run by
- Medical University of Graz
See details and how to joinNCT07297615 - 4. fázisTaking peopleHOPE Against Cancer Recurrence in HCC
- Where
- Innsbruck, Vienna
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - No phaseTaking peopleThe Dragon PLC Trial (DRAGON-PLC)
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 358 worldwide
- Run by
- Maastricht University
See details and how to joinNCT06914648 - 3. fázisTaking peopleThe ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
- Where
- Graz, Innsbruck, Klagenfurt Am Woerthersee, St. Pölten, Vienna
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT04803994 · EU 2024-512953-26-00 - No phaseTaking peopleThe DRAGON 2 Trial
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 348 worldwide
- Run by
- Maastricht University
See details and how to joinNCT05428735 - No phaseTaking peopleVienna Hypothermic Oxygenated Machine Perfusion Study
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 500
- Run by
- Medical University of Vienna
See details and how to joinNCT06418165